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background: Cardiac Troponin (cTn) levels offer prognostic information for patients with heart failure. The prognostic utility of detectable high 
sensitivity cTn in patients with heart failure in the setting of a standard cTn assay lower than 99th percentile has not been described.
Methods: High sensitivity cTn T (hs-cTnT) levels were measured in 232 sequential stable patients, with a heart failure history undergoing elective 
coronary angiography without acute coronary syndrome (cTnI, Abbott <0.3 ng/mL), with 5-year follow-up of all-cause mortality. Aminoterminal pro 
B-type natriuretic peptide (NT-proBNP, Roche) and hs-cTnT (Roche 5th gen) were measured.
results: In the cohort (mean age 68±11 years, 63% male, 34% diabetic, median NT-proBNP 1,144 pg/mL, median GFR 77.8 mL/min) the median 
hs-cTnT level was 20.1 ng/L [IQR 12.1, 20.5] and 76 subjects died by 5-years. Higher hs-cTnT provided independent prediction of a 2.6-fold 
increase in 5-year mortality (hs-cTnT < 20.1 ng/mL versus ≥ 20.1 ng/L: Hazard ratio [95% confidence interval] 2.59 [1.62-4.28], p<.0001, Figure). 
After adjusting for NT-proBNP and GFR, higher hs-cTnT still predicted a 2.0-fold increase in mortality (1.99 [1.19-3.40], p=0.008).
conclusions: Higher levels of hs-cTnT in a subset of stable heart failure patients with normal cTnI provided independent prognostic value for 
mortality prediction. These findings support the hypothesis that detectable hs-cTnT may identify high-risk patients with heart failure.
 
